about
RNAi and RNAa--the yin and yang of RNAomeThe Role of MicroRNAs in Myeloproliferative NeoplasiaCombinatorial approach to determine functional group effects on lipidoid-mediated siRNA delivery.Novel translational strategies in colorectal cancer research.Deciphering the key molecular and cellular events in neutrophil transmigration during acute inflammation.Epigenetic approaches to psychiatric disorders.Effective inhibition of foot-and-mouth disease virus (FMDV) replication in vitro by vector-delivered microRNAs targeting the 3D geneNovel functions for small RNA molecules.The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease.Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease.Dissecting the role of the S1P/S1PR axis in health and disease.Bioanalytical LC-MS of therapeutic oligonucleotides.Subcellular fate and off-target effects of siRNA, shRNA, and miRNA.Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis.Short hairpin RNA-mediated inhibition of measles virus replication in vitro.Native microRNA loop sequences can improve short hairpin RNA processing for virus gene silencing in animal cells.Request for retraction: Short interfering RNA (siRNA) as a novel therapeutic.Request for the retraction of Cepp review 33: 504-510 (2006).
P2860
Q24642007-F9263C5D-6A14-4571-8A32-7D4476BC3F59Q26739435-743C5CE9-EFF6-4FEA-AD51-7EA4E5DBF19DQ33660805-8237C95C-BB93-4491-B3B9-F6464DBE53DBQ34382804-63FA003B-3CAF-4B34-8ED2-B636FAE34298Q34951892-F64C6F3E-AD1F-473C-860F-DAE5995D1C0BQ35237163-320F14FD-3788-4217-806B-9A85C5213723Q35861780-AD4867F3-1293-42CD-8BC6-CA24F4AD9ECDQ36673371-150E25EB-A95D-4CB6-B450-7341B94DEDF3Q37646847-6E4D3BC2-A657-48FF-BCA5-99BC53FD0CF0Q37772498-DDE4BD84-D45D-4D2F-82B1-4C257FF74815Q37830235-9CA2A2E6-8B10-42D5-A2E7-498DB8110744Q37851144-ED74DA1A-DDB2-4444-BFA4-DEE1618D833DQ37950261-E819E2DA-1A58-479F-AB00-3556BAE7C0B5Q38889403-2094B0AD-14B9-4437-8895-3CF766132771Q39361870-C578E9DE-523A-41D4-9D3F-E143456EEECEQ39903624-9B942671-49B9-4EA6-BAFE-0C22A4580DECQ42544724-8C8A7EF1-75B5-408A-890A-0F3EBD886B65Q45828120-D9E57BFC-00DF-416A-BC48-8E3D14C99A9CQ45828422-F60DB1DA-153B-412A-8E50-204A6F619C48
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Short interfering RNA (siRNA) as a novel therapeutic.
@ast
Short interfering RNA (siRNA) as a novel therapeutic.
@en
type
label
Short interfering RNA (siRNA) as a novel therapeutic.
@ast
Short interfering RNA (siRNA) as a novel therapeutic.
@en
prefLabel
Short interfering RNA (siRNA) as a novel therapeutic.
@ast
Short interfering RNA (siRNA) as a novel therapeutic.
@en
P2860
P1476
Short interfering RNA (siRNA) as a novel therapeutic.
@en
P2093
Alirio J Melendez
P2860
P304
P356
10.1111/J.1440-1681.2006.04399.X
P577
2006-05-01T00:00:00Z